Trial Profile

Phase II Study Of Preoperative Chemoradiotherapy Plus Avelumab In Patients With Locally Advanced Rectal Cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 25 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Avelumab (Primary) ; Capecitabine
Indications Adenocarcinoma; Colorectal cancer; Rectal cancer
Focus Therapeutic Use
Acronyms AVANA

Most Recent Events

18 Oct 2023 Status changed from active, no longer recruiting to completed.
03 Aug 2022 Status changed from recruiting to active, no longer recruiting.
03 Jul 2021 Results assessing role of avelumab in combination with preop CTRT in patients with locally advanced rectal cancer presented at the 23rd World Congress on Gastrointestinal Cancer

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com